Company intelligence / Profile preview
Nevakar Inc.
Bridgewater, New Jersey, USAnevakar.com ↗
- Ownership
- Private
- Employees
- ~33
- Development stage
- Other
01
Overview
Nevakar focuses on developing novel injectable and ophthalmic formulations by enhancing existing approved drugs to address unmet medical needs with improved clinical outcomes. Their approach leverages patent-protected innovations around drug delivery technologies, aiming at better patient care solutions especially in hospital settings.
- Therapeutic areas
- OtherOphthalmologyNeurology
- Modalities
- Injectable pharmaceuticalsOphthalmic drugsLong acting injectablesFocus on reformulated existing molecules for enhanced delivery and efficacy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Nevakar Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nevakar Inc..